{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:24:22Z","timestamp":1794273862861,"version":"4.9.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006484","name":"AbbVie Deutschland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with an adverse impact on patients' quality of life (QoL).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To quantify QoL impairment in patients in Germany suffering from HS and to identify the parameters associated with QoL impairment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A non-interventional, cross-sectional, mono-centric study with 500 HS patients. QoL data (measured using the Dermatology Life Quality Index; DLQI) and demographic, anamnestic, clinical, and blood parameters were collected. All patients were examined by dermatologists that documented the skin alterations. QoL data from 462 HS patients were available and evaluated.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    The mean (\u00b1 standard deviation) DLQI score of HS patients was 13.18 \u00b1 7.99. Approximately 40% and 20% of HS patients declared very large and extremely large QoL impairment, respectively. The degree of QoL disturbance correlated with the severity of skin alterations, blood leucocyte count and, in particular, with anogenital localization and the presence of nodules and fistulas. Furthermore, QoL impairment was associated with specific comorbidities, such as adiposity and back pain, but not with HS family history. QoL impairment was not influenced by whether or not the patients had undergone resection surgery or antibiotic treatment but was more severe in HS patients that had undergone abscess lancing compared to patients without such treatment in the past.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Limitations:<\/jats:bold>\n                    It was a mono-centric study and most data were obtained from self-administered patient questionnaires. The association of QoL with type of treatment was analyzed for abscess lancing, resection surgery, and antibiotic treatment. Further therapeutic modalities recommended in the guidelines were not investigated.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    A profound impairment in QoL was present in patients with HS, and this was higher than that observed in other studied dermatoses. The degree of impairment correlated with the extent of cutaneous and some extra-cutaneous alterations. Surgical and conventional medicamentous therapies of HS were not associated with long-lasting reduction of QoL impairment. Our data support the implementation of patient-reported outcome measures for the assessment of therapy responses.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.676241","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T12:38:15Z","timestamp":1619527095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients"],"prefix":"10.3389","volume":"8","author":[{"given":"Sylke","family":"Schneider-Burrus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Tsaousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Barbus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Huss-Marp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1203475420972348","article-title":"Race-specific prevalence of hidradenitis suppurativa","volume":"25","author":"Sachdeva","year":"2021","journal-title":"J Cutan Med Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/jdv.16783","article-title":"Hidradenitis suppurativa - prevalence analyses of German statutory health insurance data","volume":"35","author":"Schneider-Burrus","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/bjd.19556","article-title":"Aetiology and pathogenesis of hidradenitis suppurativa","volume":"183","author":"Wolk","year":"2020","journal-title":"Br J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8436","DOI":"10.3390\/ijms21228436","article-title":"Cytokine pathways and investigational target therapies in hidradenitis suppurativa","volume":"21","author":"Del Duca","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1600-0625.2009.00915.x","article-title":"Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis","volume":"19","author":"von Laffert","year":"2010","journal-title":"Exp Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjd.16019","article-title":"Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop","volume":"178","author":"Hessam","year":"2018","journal-title":"Br J Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/bjd.17854","article-title":"A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26","volume":"181","author":"Scala","year":"2019","journal-title":"Br J Dermatol."},{"key":"B12","article-title":"Activity and components of the G-CSF pathway in hidradenitis suppurativa","volume-title":"Br J Dermatol","author":"Wolk","year":"2021"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jid.2018.11.018","article-title":"The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction","volume":"139","author":"Witte-Handel","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/bjd.15424","article-title":"Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa\/hidradenitis suppurativa","volume":"177","author":"Wolk","year":"2017","journal-title":"Br J Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1159\/000448838","article-title":"High prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa","volume":"232","author":"Schneider-Burrus","year":"2016","journal-title":"Dermatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaad.2018.06.028","article-title":"High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa","volume":"80","author":"Rondags","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/bjd.17578","article-title":"Substantially reduced life expectancy in patients with hidradenitis suppurativa: a finnish nationwide registry study","volume":"180","author":"Tiri","year":"2019","journal-title":"Br J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/ddg.12067","article-title":"Depression is a frequent co-morbidity in patients with acne inversa","volume":"11","author":"Kurek","year":"2013","journal-title":"J Dtsch Dermatol Ges."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1111\/bjd.16603","article-title":"Profound consequences of hidradenitis suppurativa: a review","volume":"183","author":"Matusiak","year":"2020","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/PPA.S121218","article-title":"Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People's Republic of China","volume":"11","author":"Zhang","year":"2017","journal-title":"Patient Prefer Adherence."},{"key":"B28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijwd.2017.07.001","article-title":"Quality of life in mild and severe alopecia areata patients","volume":"4","author":"Abedini","year":"2018","journal-title":"Int J Womens Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jdv.13757","article-title":"Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study","volume":"31","author":"Richter","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"108624","DOI":"10.1155\/2013\/108624","article-title":"Evaluating of life quality in patients with acne vulgaris using generic and specific questionnaires","volume":"2013","author":"Ghaderi","year":"2013","journal-title":"Dermatol Res Pract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000363407","article-title":"To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index","volume":"229","author":"Ingordo","year":"2014","journal-title":"Dermatology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.adengl.2017.06.001","article-title":"Impact of vitiligo on quality of life","volume":"108","author":"Morales-Sanchez","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-4362.2002.01436.x","article-title":"Atopic dermatitis is associated with a decrement in health-related quality of life","volume":"41","author":"Kiebert","year":"2002","journal-title":"Int J Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2340\/00015555-2741","article-title":"Suicidal ideation in adult patients with atopic dermatitis: a German cross-sectional study","volume":"97","author":"Dieris-Hirche","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/bjd.17128","article-title":"Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management","volume":"179","author":"Augustin","year":"2018","journal-title":"Br J Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00403-015-1567-x","article-title":"Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis","volume":"307","author":"Schmitt","year":"2015","journal-title":"Arch Dermatol Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00042728-200404000-00013","article-title":"Skin cancer and quality of life: assessment with the Dermatology Life Quality Index","volume":"30","author":"Rhee","year":"2004","journal-title":"Dermatol Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s13187-018-1368-y","article-title":"Quality of life in patients with non-melanoma skin cancer: implications for healthcare education services and supports","volume":"34","author":"Abedini","year":"2019","journal-title":"J Cancer Educ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2340\/00015555-2815","article-title":"Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa","volume":"98","author":"Matusiak","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1203475417745826","article-title":"The contribution of malodour in quality of life of patients with hidradenitis suppurativa","volume":"22","author":"Alavi","year":"2018","journal-title":"J Cutan Med Surg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1684\/ejd.2019.3552","article-title":"Assessing the psychological burden of patients with hidradenitis suppurativa","volume":"29","author":"Frings","year":"2019","journal-title":"Eur J Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/life11010034","article-title":"Quality-of-life impairment among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients","volume":"11","author":"Krajewski","year":"2021","journal-title":"Life."},{"key":"B43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40257-014-0105-5","article-title":"Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study","volume":"16","author":"Alavi","year":"2015","journal-title":"Am J Clin Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000455236","article-title":"The burden of hidradenitis suppurativa in a cohort of patients in Southern Finland: a pilot study","volume":"3","author":"Kluger","year":"2017","journal-title":"Skin Appendage Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00403-019-02025-5","article-title":"Factors affecting quality of life in patients with hidradenitis suppurativa","volume":"312","author":"Jorgensen","year":"2020","journal-title":"Arch Dermatol Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/CCID.S93619","article-title":"Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa","volume":"9","author":"Fotiadou","year":"2016","journal-title":"Clin Cosmet Investig Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.676241\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T12:38:18Z","timestamp":1619527098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.676241\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":46,"alternative-id":["10.3389\/fmed.2021.676241"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.676241","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"article-number":"676241"}}